BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38483586)

  • 1. Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.
    Wang L; Wang B; Ai Q; Zhang Y; Lv X; Li H; Ma X; Zhang X
    Int Urol Nephrol; 2017 Jun; 49(6):995-1005. PubMed ID: 28238148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy.
    Novara G; Ficarra V; Mocellin S; Ahlering TE; Carroll PR; Graefen M; Guazzoni G; Menon M; Patel VR; Shariat SF; Tewari AK; Van Poppel H; Zattoni F; Montorsi F; Mottrie A; Rosen RC; Wilson TG
    Eur Urol; 2012 Sep; 62(3):382-404. PubMed ID: 22749851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
    Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    World J Urol; 2024 Mar; 42(1):152. PubMed ID: 38483586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group).
    Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Ann Surg Oncol; 2024 Mar; 31(3):2154-2162. PubMed ID: 38200385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
    Sugino Y; Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    Clin Genitourin Cancer; 2022 Dec; 20(6):593-600. PubMed ID: 35773146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group).
    Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    J Robot Surg; 2023 Aug; 17(4):1609-1617. PubMed ID: 36928750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group).
    Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    Jpn J Clin Oncol; 2023 Apr; 53(5):443-451. PubMed ID: 36708227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5.
    Panunzio A; Sorce G; Hoeh B; Hohenhorst L; Tappero S; Nimer N; Rajwa P; Tian Z; Terrone C; Chun FKH; Briganti A; Saad F; Shariat SF; Cerruto MA; Antonelli A; Karakiewicz PI
    Prostate; 2023 Feb; 83(3):268-276. PubMed ID: 36336728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group).
    Kato D; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Asian J Endosc Surg; 2022 Oct; 15(4):745-752. PubMed ID: 35508895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI-RADS v2 Findings of MRI and Positive Biopsy Core Percentage would Predict Pathological Extraprostatic Extension in Patients who Underwent Robot Assisted Radical Prostatectomy: A Retrospective Study.
    Yamashita S; Kohjimoto Y; Sato H; Kikkawa K; Sonomura T; Hara I
    Urol J; 2022 Dec; 19(6):438-444. PubMed ID: 35466392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following radical prostatectomy or external beam radiation for veterans with Gleason 9 and 10 prostate cancer.
    Chao HH; Soni PD; Dahman B; Stilianoudakis SC; Ford H; Singh R; Freedland SJ; Moghanaki D; Vapiwala N; Chang MG
    Cancer Med; 2022 Aug; 11(15):2886-2895. PubMed ID: 35289111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy.
    Wenzel M; Würnschimmel C; Chierigo F; Mori K; Tian Z; Terrone C; Shariat SF; Saad F; Tilki D; Graefen M; Mandel P; Roos FC; Chun FKH; Karakiewicz PI
    Eur Urol Focus; 2022 May; 8(3):710-717. PubMed ID: 33933420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
    Wilkins LJ; Tosoian JJ; Reichard CA; Sundi D; Ranasinghe W; Alam R; Schwen Z; Reddy C; Allaf M; Davis JW; Chapin BF; Ross AE; Klein EA; Nyame YA
    Cancer; 2021 May; 127(9):1425-1431. PubMed ID: 33721334
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.